HealthQuill accelerated approval program
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Medical Pharma

FDA’s accelerated approval of cancer drugs is hasty and doubtful, says new report

HQ Team April 10, 2024:  A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval.

Read More
X